People news from the 10/24/06 News Brief

MANUFACTURERS Teva Pharmaceutical announced that Israel Makov plans to retire as CEO in 2007. Shlomo Yanai will join as CEO designate during the first part of 2007. AGENCIES Fission Communications has promoted Nancy Hausman from account manager to account supervisor, client services. In her new role, Nancy will continue to spearhead initiatives for several key Fission clients, including AstraZeneca, Cephalon, Merck, and Takeda. Medical Broadcasting Company (MBC) has hired Michael du Toit as SVP, management supervisor. His primary role will be to provide strategic counsel and manage the company's relationship with a major pharmaceutical firm client, MBC said. Previously, he was VP, client services and business development at TMX Communications in Philadelphia. He has also worked as the EVP at Ventiv Health, VP of marketing at GlaxoWellcome and as group account supervisor for BBD&O. AbelsonTaylor has announced the following new hires and promotions. Sarah Jenkins has been promoted from account executive to senior account executive, working on products in the insomnia drugs category. Nina Brakel joined the agency as senior account executive, providing support for two diabetes drugs. Lauren Claytor has been promoted from assistant account executive to account executive, working on accounts in the diabetes category. Jayme Fogel has been promoted from assistant account executive to account executive, working in the insomnia drugs category.   MEDIA Wendy Raupers has joined Lebhar-Friedman division Dowden Health Media as sales director of special programs for the professional division. Raupers joins from Advanstar where she held a number of titles, including associate publisher of RN magazine, and senior account manager on Medical Economics.  
You must be a registered member of MMM to post a comment.

Email Newsletters

Specialty medicines continue to be a hot category, one in which spending has surged behind products that treat medicine's most complex diseases. This eBook lays out the needs and hurdles along the specialty drug pathway, explaining how stakeholders are working to get meds into patients' hands and ease their experience. Click here to download.